# PHS 2023-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)

Source: https://welltoldgrants.com/grants/pa-23-231-phs-2023-2-omnibus-solicitation-of-the-nih/  
Official notice: https://www.grants.gov/search-results-detail/349222

> National Institutes of Health offered grants to small businesses. Applications closed on April 5, 2024.

| Field | Value |
|---|---|
| Opportunity number | PA-23-231 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | April 5, 2024 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.361, 93.394, 93.395, 93.867 |

## Who can apply

- Small businesses

Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.

## What the grant funds

This Notice of Funding Opportunity Announcement (NOFO), issued by the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) invites eligible United States small businesses to submit Small Business Innovation Research (SBIR) grant applications. United States small businesses that have the research capabilities and technological expertise to contribute to the R and D mission(s) of the NIH and CDC awarding components identified in this NOFO are encouraged to submit SBIR grant applications in response to identified topics (see PHS 2022-2 SBIR/STTR Program Descriptions and Research Topics for NIH, CDC, and FDA). This Parent Funding Opportunity Announcement requires that at least 1 clinical trial be proposed. The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions.

## Questions people ask

### Is PA-23-231 still open?

No. It closed on April 5, 2024.

### Who can apply for PHS 2023-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)?

National Institutes of Health accepted applications from small businesses. The notice adds further conditions, so read its eligibility section.

### What is the deadline for PHS 2023-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)?

Closed April 5, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### Who has been funded under PA-23-231?

NIH RePORTER lists 79 projects funded under PA-23-231 in fiscal 2024 to 2026, at 71 institutions. The most were at Oregon Res Behavioral Intervention Strat, 3-C Institute for Social Development, Marker Therapeutics, Inc.

### Who has won Nursing Research grants before?

The largest recipients over five fiscal years were The Trustees of the University of Pennsylvania, The Johns Hopkins University, The Trustees of Columbia University in the City of New York. The program made 786 awards worth $725 million in that time.